What are the ACCF/AHA guidelines for the management of valvular heart disease?
The ACCF/AHA guidelines for the management of valvular heart disease recommend anticoagulation in patients with mitral stenosis and a prior embolic event, even in sinus rhythm (Class I; Level of Evidence B), and in patients with mitral stenosis with left atrial thrombus (Class I; Level of Evidence B). Aspirin therapy is recommended for patients with mitral valve prolapse who experience TIAs (Class I; Level of Evidence C) and warfarin for these patients with a history of stroke and mitral regurgitation, AF, or left atrial thrombus (Class I; Level of Evidence B).